Teratogens
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment (NCT05883761) | Elizabeth Glaser Pediatric AIDS Foundation | 2021-09-07 |
| Electronic Notification of Teratogenic Risks (NCT00766207) | University of Pittsburgh | 2008-10-01 |
Track Teratogens automatically
Every clearance here is in the API, with alerts when new ones post.